Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 study assessing safety and immunogenicity of an Enterovirus 71 (EV71) vaccine conducted by Taiwan's National Health Research Institutes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus Infection

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Enterovirus Infection | Phase 1 | Status: COMPLETED